Akero Therapeutics (NASDAQ:AKRO – Get Rating) had its price target hoisted by stock analysts at HC Wainwright from $62.00 to $64.00 in a research note issued on Wednesday, The Fly reports. HC Wainwright’s target price would indicate a potential upside of 23.89% from the stock’s current price. Several other brokerages have also recently weighed in […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating)’s stock price shot up 5% during mid-day trading on Monday . The company traded as high as $49.15 and last traded at $49.08. 174,925 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 611,627 shares. The stock had previously closed at […]
Akero Therapeutics (NASDAQ:AKRO – Get Rating) had its price target cut by HC Wainwright from $64.00 to $62.00 in a research report released on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Akero Therapeutics’ Q2 2023 earnings at ($0.60) EPS, Q3 2023 earnings at ($0.68) EPS, Q4 2023 earnings at ($0.87) EPS, […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) – Research analysts at HC Wainwright raised their Q2 2023 EPS estimates for shares of Akero Therapeutics in a research note issued to investors on Tuesday, May 16th. HC Wainwright analyst E. Arce now anticipates that the company will post earnings per share of ($0.60) for the quarter, […]
Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) gapped down prior to trading on Tuesday after HC Wainwright lowered their price target on the stock from $64.00 to $62.00. The stock had previously closed at $47.71, but opened at $45.98. Akero Therapeutics shares last traded at $45.92, with a volume of 39,226 shares traded. […]